Calvary Inc is committed to protecting any personal information that you may provide to us. In particular, we believe it is important for you to know how we treat information about you that we may receive from this Web site.
In general, you can visit this Web site without telling us who you are or revealing any information about yourself. Our web servers collect the domain names, of visitors. Our web server also seek to place a "cookie" on your computer's hard drive which allows the server to determine the computer when it visits again, in order to track statistical information about navigation to and throughout certain areas of our site. This cookie is not used to obtain your name or any personal data, and the information that is tracked is used only for internal purposes, such as to improve site navigation and to measure the effectiveness of our promotional placements, and is not shared with anyone other than contractors who assist
We use third-party technology to place advertisements on our web site. This technology will install a small "cookie" file on your computer when you view an ad. These cookies will not contain any information that personally identifies you but they will contain a randomly generated number that is unique to your browser and can be recognized by our site if you click through to our site from one of our ads. This allows us to keep track of how many unique visitors we have to our site and from what ads you entered, so that we can measure the effectiveness of our ads and ad placements.
This Web site is not intended for persons under 13 years of age. We do not knowingly solicit or collect personal information from or about children, and we do not knowingly market our products or services to children.
Domain name information that we collect is not used to personally identify you and instead is aggregated to measure the number of visits, average time spent on the site, pages viewed, ect. We use this information to measure the use of our site and to improve the content of our site.
When other information is collected from you, such as your name and e-mail address, we generally let you know at the time of collection how we will use the personal information. Usually, we use the personal information you provide only to respond to your inquiry or to process your request. At times we may ask for your feedback pertaining to our site, these feedbacks will contain your e-mail address. We reserve the right to contact you by e-mail in response to your request or comments.
We do not share, sell, or lease personal information about you to any third-parties for their marketing use. We will release information about you if you direct us to do so, if we are required by law to do so, or in other legally limited circumstances.
Links to Other Sites
Calvary Inc.'s Web site may contain links to other sites. While we try to link only to sites that share our high standards and respect for your privacy, we are not responsible for the content, security, or privacy practices employed by other sites.
By accessing this Web site or digital service, you specifically acknowledge and agree that (i) Associated Press text, photo, graphic, audio and/or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium; (ii) No Associated Press materials nor any portion thereof may be stored in a computer except for personal and non-commercial use; (iii) The Associated Press and Calvary Inc. will not be held liable for any delays, inaccuracies, errors or omissions there from or in the transmission or delivery of all or any part thereof or for any damages arising from any of the foregoing; (iv) The Associate Pres is an intended third party beneficiary of these terms and conditions and it may exercise all rights and remedies available to it; and (v) The Associate Press reserves the right to audit possible unauthorized commercial use of AP materials or any portion thereof at any time.
Changes to this Policy
Mylan Pharmaceuticals based in Canonsburg under increasing pressure from consumers, politicians and the media, reduced the cost of EpiPen their anti-allergy injection medicine. An EpiPen two pack costs $600, compared with $100 charged when first acquired in 2007. Blaming high health insurance deductibles, Mylan will help by doubling their patient assistance program covering incomes up to 400 percent of the federal poverty level offering discounts u Critics say Mylan needs to lower the price of the drug not to make it easier to pay for it.
Given the controversy surrounding the Clinton Foundation should it be shut down permanently?